Cancer survival in Sweden in 1961-1991 is presented as a comprehensive report from the Swedish Cancer Registry.
The report shows both successes and failures, confirms some earlier published results and presents some new findings worth further analysis.
Survival has increased for female breast cancer, malignant melanoma, cancers of the testis and thyroid gland, acute leukemia, and Hodgkin's disease.
No improvements are found for multiple myeloma or cancers of the liver, gall bladder, and pancreas.
Small increases are shown for colorectal cancer and cancers of the stomach, oesophagus, and kidney.
Increases in postoperative survival are shown for sites dominated by histologically benign tumors, i.e., intracranial neurinoma, meningioma, and cancers of the endocrine glands such as parathyroid tumors.
From 1970-1972 to 1980-1982 the 10-year relative survival rate (RSR) increased from 30% to 38% for males and from 44% to 51% for females.
Hence, cancer survival for all cases combined has approached the survival of the general population somewhat.
Most of the increases took place in the 1970's. Changes in the distribution of incidence towards cancer sites with better prognoses account for some 10-20% of the observed increases in RSR, whereas the aging of the cancer population reduces the upward trend in RSR for all cases combined by some 1-2%. Cancer patients have poorer survival than the population long after 5 years of follow-up.
Mots-clés Pascal : Tumeur maligne, Hémopathie maligne, Pronostic, Survie, Homme, Etude statistique, Echelon national, Suède, Europe
Mots-clés Pascal anglais : Malignant tumor, Malignant hemopathy, Prognosis, Survival, Human, Statistical study, National scope, Sweden, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0577377
Code Inist : 002B04B. Création : 01/03/1996.